-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Arcturus Therapeutics Holdings Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q2 2018 to Q2 2024.
- Arcturus Therapeutics Holdings Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$17.2M, a 67.2% increase year-over-year.
- Arcturus Therapeutics Holdings Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$72M, a 190% decline year-over-year.
- Arcturus Therapeutics Holdings Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$29.7M, a 418% decline from 2022.
- Arcturus Therapeutics Holdings Inc. annual Net Income (Loss) Attributable to Parent for 2022 was $9.35M.
- Arcturus Therapeutics Holdings Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$204M, a 182% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)